CDRH Inspectors To Tour Unlucky Irish Facility After Taxus Recall Expands

FDA will inspect Boston Scientific's Galway, Ireland stent manufacturing facility to ensure the plant's quality control processes are consistent with those implemented at the firm's Maple Grove, Minn. site

More from Archive

More from Medtech Insight